Skip to main content
OpenTrials

Clinical trial condition

Cataplexy

Explore clinical trials studying Cataplexy. Study availability and eligibility vary by location and protocol.

28 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Cataplexy trial results

Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

NCT07598708

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +11 more
Locations
  • Miami, Florida Miami, Florida, United States
  • Miami Lakes, Florida Miami Lakes, Florida, United States
  • Denver, North Carolina Denver, North Carolina, United States
  • Huntersville, North Carolina Huntersville, North Carolina, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

NCT07455383

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +10 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

NCT07675135

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +9 more
Locations
  • Phoenix Medical Group, PC Peoria, Arizona, United States
  • Santa Monica Clinical Trials Los Angeles, California, United States
  • Alpine Clinical Research Center, Inc Boulder, Colorado, United States
  • PharmaDev Clinical Research Institute, LLC Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

NCT03881852

Conditions
Cataplexy, Cataplexy Narcolepsy, Disorders of Excessive Somnolence, +7 more
Locations
  • CONCERT Study Site Birmingham, Alabama, United States
  • CONCERT Study Site Alameda, California, United States
  • CONCERT Study Site Santa Ana, California, United States
  • CONCERT Study Site Boulder, Colorado, United States
View all 14 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

NCT06358950

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Redwood City, California, United States
  • Alkermes Investigator Site San Francisco, California, United States
  • Alkermes Investigational Site Santa Ana, California, United States
View all 45 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

NCT05059223

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Clinical Research Site Alabaster, Alabama, United States
  • Clinical Research Site Peoria, Arizona, United States
  • Clinical Research Site Phoenix, Arizona, United States
  • Clinical Research Site Redwood City, California, United States
View all 50 locations
View Trial Details
Completed

A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

NCT05113745

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Clinical Research Site Phoenix, Arizona, United States
  • Clinical Research Site Boulder, Colorado, United States
  • Clinical Research Site Colorado Springs, Colorado, United States
  • Clinical Research Site Brandon, Florida, United States
View all 25 locations
View Trial Details
Completed

An Open Label Study of FT218 in Subjects With Narcolepsy

NCT04451668

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +12 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Sleep Medicine Redwood City, California, United States
  • SDS Clinical Trials Santa Ana, California, United States
  • Alpine Clinical Research Center Boulder, Colorado, United States
View all 29 locations
View Trial Details

Related conditions